EQT Life Sciences
3 rounds tracked since 10 January 2026.
- Rounds
- 3
- Led
- 0
- Capital in these rounds
- $278M
Sectors
Countries
Rounds
- Vaderis TherapeuticsDevelops targeted therapies for rare vascular diseases $152MSeries B · 11 Aug
- XeltisDevelops living vascular access implants for hemodialysis patients $23.3MGrowth · 28 Jul
- Kinaset TherapeuticsDevelops a novel inhaled therapeutic candidate for respiratory diseases. $103MSeries B · 10 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise